文章摘要

参考文献/References

[1]Schmauss D,Weis M.Cardiac allograft vasculopathy:Recent Developments[J].Circulation,2008,117(16):2131-2141.
[2]Ramzy D,Rao V,Brahm J,et al.Cardiac allograft vasculopathy:a review[J].Can J Surg,2005,48(4):319-327.
[3]Suzuki J,Isobe M,Morishita R,et al.Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments[J].Circ J,2010,74(2):233-239.
[4]Aranda JM Jr,Hill J.Cardiac transplant vasculopathy[J].Chest,2000,118(6):1792-1800.
[5]Vallantine HA.Cardiac allograft vasculopathy:central role of endothelial injury leading to transplant“atheroma”[J].Transplantation,2003,76(6):891-899.
[6]Kwun J,Hu H,Schadde E,et al.Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients[J].J Immunol,2007,179(12):8016-8025.
[7]van Loosdregt J,van Oosterhout MF,Bruggink AH,et al.The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response[J].Circulation,2006,114(15):1599-1607.
[8]Perrault LP,Mahlberg F,Breugnot C,et al. Hypercholesterolemia increases coronary endothelial dysfunction,lipid content,and accelerated atherosclerosis after heart transplantation[J].Arterioscler Thromb Vasc Biol,2000,20(3):728-736.
[9]Kobashigawa JA,Starling RC,Mehra MR,et al.Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients[J].J Heart Lung Transplant,2006,25(9):1063-1069.
[10]Chan JC,Cheung JC,Stehouwer CD,et al.The central roles of obesity associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome-an analysis by structural equation modeling[J].Int J Obes Relat Metab Disord,2002,26(7):994-1008.
[11]Potena L,Valantine HA.Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets[J].Endocrinol Metab Clin North Am,2007,36(4):965-981.
[12]Mahle WT,Fourshee MT,Naftel DM,et al.Does cytomegalovirus serology impact outcome after pediatric heart transplantation?[J].J Heart Lung Transplant,2009, 28(12):1299-1305.
[13]Hussain T, Burch M,Fenton MJ,et al.Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children[J].Circulation,2007,115(13):1798-1805.
[14]Hunter AL,Kerjner A,Mueller KJ,et al. Cytochrome p450 2C enzymes contribute to peritransplant ischemic injury and cardiac allograft vasculopathy[J].Am J Transplant,2008,8(8):1631-1638.
[15]Arora S,Gullestad L,Wergeland R, et al.Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation[J].Transplantation,2007,83(10):1308-1315.
[16]张明奎,杨进福,胡建国.血管平滑肌肌动蛋白α在移植心脏血管病变及纤维化中的作用[J].中南大学学报(医学版),2009,34(4):323-326.
[17]Sai S,Iwata A,Thomas R,et al.Vascular cell adhesion molecule-1 up-regulation and phenotypic modulation of vascular smooth muscle cells predate mononuclear infiltration in transplant arteriopathy[J].J Thorac Cardiovasc Surg,2001,122(3):508-517.
[18]Wu YW,Yen RF,Lee CM,et al.Diagnostic and prognostic value of dobutamine thallium-201 single-photon emission computed tomography after heart transplantation[J].J Heart Lung Transplant,2005,24(5):544-550.
[19]Eroglu E,Dhooge J,Sutherland GR,et al.Quantitative dobutamine stress echocardiography for the early detection of cardiac allograft vasculopathy in heart transplant recipients[J].Heart,2008,94(2):e3.
[20]Sharples LD,Jackson CH,Parameshwar J,et al.Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy[J].Transplantation,2003,76(4):679-682.
[21]Spes CH,Klauss B,Rieber J,et al.Functional and morphological findings in heart transplant recipients with a normal coronary angiogram: an analysis by dobutamine stress echocardiography, intracoronary Doppler and intravascular ultrasound[J].J Heart Lung Transplant,1999,18(5):391-398.
[22]Lee CM,Wu YW,Jui HY,et al.Intravascular ultrasound correlates with coronary flow reserve and predicts the survival in angiographically normal cardiac transplant recipients[J].Cardiology,2008,109(2):93-98.
[23]Vassalli G,Kaski JC,Tousoulis D,et al.Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation[J].J Heart Lung Transplant,1996,15(6):612-619.
[24]Klauss V,Konig A,Spes C,et al.Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy[J].Am J Cardiol,2000,85(2):266-269.
[25]Pethig K,Heublein B,Wahlers T,et al.Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia[J].J Heart Lung Transplant,2004,23(1):61-66.
[26]Erinc K,Yamani MH,Starling RC,et al.The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound[J].J Heart Lung Transplant,2005,24(8):1033-1038.
[27]Kobashigawa JA,Moriguchi JD,Laks H,et al.Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients[J].J Heart Lung Transplant,2005,24(11):1736-1740.
[28]Simpson L,Lee EK,Hott BJ,et al.Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy[J].J Heart Lung Transplant,2005,24(9):1211-1217.
[29]Radovancevic B,McGiffin DC,Kobashigawa JA,et al.Retransplantation in 7,290 primary transplant patients:a 10-year multi-institutional study[J].J Heart Lung Transplant,2003,22(8):862-868.

我们的网站为什么显示成这样？

心脏移植后冠状动脉血管病变(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics